Latest News and Press Releases

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Japan Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9), By Delivery Method (Ex Vivo), By Application (Genetic...

Austin, TX, USA, July 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “CRISPR Gene Editing Market Size, Trends and Insights By Product (Kits and...

Austin, TX, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell...

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Gene and Cell Therapies Targeting CNS Disorders Market - A Global and Regional Analysis: Focus on Drug and Region - Analysis and Forecast, 2025-2035"...

SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer.

Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application...

Cytosurge appoints Magid Haddouchi, PhD, as CCO and joins key events worldwide to showcase FluidFM tech for single-cell and genome engineering solutions.

CAMBRIDGE, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based...

Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Global CRISPR Cas9 Market Opportunity & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's offering. Antecedently,...

Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system.